Showing results (501-510 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|December 15, 2015
Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the USPamela P Pei, Milton C Weinstein, X Cynthia Li, et al.
HIV Clinical Trials|February 19, 2017
Feasibility of identifying out of care HIV-positive patients in a hospital setting and enrolling them in a retention interventionJessica A Davila, Christine Hartman, Jeffrey Cully, et al.
HIV Clinical Trials|November 25, 2003
Long-term outcome of HIV-infected patients with multinucleoside-resistant genotypesOscar Gallego, Carmen d Mendoza, Pablo Labarga, et al.
HIV Clinical Trials|November 25, 2003
Elevated blood pressure in HIV-infected individuals receiving highly active antiretroviral therapyDominic C Chow, Scott A Souza, Randi Chen, et al.
HIV Clinical Trials|July 13, 2004
Impact of chronic hepatitis C on HIV-1 disease progressionJuan Carlos Martín, Jesús Castilla, Mariola López, et al.
HIV Clinical Trials|July 13, 2004
Health-related quality of life in HIV-infected naive patients treated with nelfinavir or nevirapine associated with ZDV/3TC (the COMBINE-QoL substudy)A Casado, X Badia, E Consiglio, et al.
HIV Clinical Trials|July 13, 2004
Clinical characteristics of gastrointestinal lymphomas associated with AIDS (GI-ARL) and the impact of HAARTSridhar Srinivasan, Kenichi Takeshita, Beata Holkova, et al.
HIV Clinical Trials|July 13, 2004
Nitric oxide production in HIV-1 infected patients receiving intermittent cycles of interleukin-2 and antiretroviralsDonato Torre, Filippo Speranza, Silvia Ghezzi, et al.
HIV Clinical Trials|March 6, 2004
Adherence, quality of life, and general satisfaction with co-formulated zidovudine, lamivudine, and abacavir on antiretroviral-experienced patientsBonaventura Clotet, Jorge Carmena, Federico Pulido, et al.
HIV Clinical Trials|November 25, 2004
Cost-effectiveness of lopinavir/ritonavir versus nelfinavir as the first-line highly active antiretroviral therapy regimen for HIV infectionKit N Simpson, Michelle P Luo, Elinor Chumney, et al.
Pageof 68